Filter
715
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
368
Studies & Reports
132
Guidelines
119
Manuals
34
Strategic & Response Plan
34
Fact sheets
10
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Kenya
31
Global
30
Nigeria
20
Ghana
20
Ethiopia
19
Uganda
19
Sierra Leone
13
Western and Central Europe
13
Nepal
12
Zambia
12
Tanzania
12
South Africa
12
Bangladesh
12
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Africa
8
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Rwanda
6
Latin America and the Carribbean
6
Indonesia
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Southern Africa
1
Uzbekistan
1
Australia
1
Vietnam
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
57
Pharmacy & Technologies
31
Public Health
29
Key Resources
16
Women & Child Health
13
Capacity Building
4
Toolboxes
Pharmacy
84
AMR
81
COVID-19
53
HIV
47
TB
37
Mental Health
34
Planetary Health
16
Ebola
14
Rapid Response
14
NTDs
13
NCDs
12
Global Health Education
11
Health Financing Toolbox
9
Conflict
5
Specific Hazards
5
Caregiver
4
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc
...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
MMWR Morb Mortal Wkly Rep. ePub: 4 December 2020. DOI: http://dx.doi.org/10.15585/mmwr.mm6949e2
10 December 2020
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may
...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation
...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in
...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that
...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio
...
National Essential Diagnostic List
recommended
The Tripartite AMR Country Self-Assessment Survey (TrACSS) helps to monitor country progress on the implementation of AMR national actions plans and has been administered on an annual basis by the Tripartite organizations (Food and Agriculture Organization of the United Nations (FAO), World Organisa
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
Saúde Soc. São Paulo, v.30, n.1, e200450, 2021
Desde março de 2020, quando a Organização Mundial de Saúde declarou que o mundo vivia uma pandemia de covid-19, acompanhamos um quadro sanitário sem precedentes nos últimos 100 anos. As medidas atuais contra a
...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t
...
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
